A recent study indicates that individuals who discontinue new GLP-1 drugs like Mounjaro or Wegovy may regain lost weight far faster than those who stop conventional diet and exercise plans.
Research printed in a major health publication points out that while obese people can lose a large proportion of their total mass while using the jabs, the weight is regained at an estimated rate of 0.8 kg per month once they quit.
"Users buying these drugs need to be cognizant of the risk of rapid weight regain when the treatment concludes," warns researcher Dr. Susan Jebb.
Such speed of recovery means a reversion to original mass within about one and a half years.
Analyzing Approaches
The study, which reviewed 37 of trials involving over 9,000 of patients, contrasted the outcomes of the injectable medications with older methods.
Researchers emphasize that individuals who shed pounds through dieting usually see a slower creep back—around 100 grams monthly—once they finish.
The Reason for the Fast Regain
Experts propose the mode of action of the injections accounts for the heightened rebound.
GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which controls hunger.
"Long-term administration of the hormone concentrations far above than the body's typical production could lead to the body to produce less of its endogenous hormone, and could reduce responsiveness to its actions," noted Dr. Adam Collins, a dietetics expert.
"Withdrawal of this medication leads to appetite is uncontrolled, making overeating a significant risk."
An Ongoing Condition?
Health authorities advise the jabs for people with weight-linked health risks, accompanied by prescribed lifestyle changes.
A number of clinicians contend that, considering the likelihood of relapse, the therapy might need to be ongoing.
This view is echoed by pharmaceutical companies, who note that the results "highlight the persistent character of excess weight," comparing it to managing diseases like diabetes.
User Testimonies
Individuals who have stopped the jabs report a intense resurgence of appetite.
"It felt as if something that goes on and you're instantly extremely hungry," recalled an individual.
This difficulty is compounded if individuals have not adopted lasting dietary or behavioural changes during therapy.
Widespread Adoption
Recent estimates show that millions of people in the UK have used weight-loss jabs in the last 12 months, with demand continuing to grow.
- Use is higher among females compared to men.
- The middle-aged age group shows the highest usage rates.
- A large proportion access the medications through private healthcare rather than the NHS.
In conclusion, experts stress that while GLP-1 drugs are powerful agents for shedding pounds, they are not a magic solution and long-term success hinges on integrated behavioural changes.
